PATRON, NCT04557501: PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer |
|
|
| Active, not recruiting | 3 | 800 | Canada | PSMA PET/CT guided intensification of therapy, Control Arm | Centre hospitalier de l'Université de Montréal (CHUM), Canadian Cancer Society (CCS), Lantheus Medical Imaging, British Columbia Cancer Agency, London Health Sciences Centre, Princess Margaret Hospital, Canada, Tom Baker Cancer Centre, McMaster University, Institute of Health Economics, Canada, Queen's University | Prostate Cancer | 01/29 | 01/29 | | |
NCT03945162: Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients |
|
|
| Recruiting | 2 | 125 | Canada, US | Ruvidar® (TLD-1433) Bladder infusion and PDT | Theralase® Technologies Inc., University Health Network, Toronto, Pharma eMarket | Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG | 06/25 | 12/25 | | |
